Trending Stock News

Sun Valley Gold Has Lowered Iamgold (IAG) Stake By $4.25 Million; Dentsply International (XRAY) Sentiment Is Infinity

DENTSPLY SIRONA Inc. designs, develops, makes, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company has market cap of $14.91 billion. It operates through two divisions, Dental and Healthcare Consumables; and Technologies. It currently has negative earnings. The firm provides dental consumable products, including endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprising dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Sun Valley Gold Llc decreased Iamgold Corp (IAG) stake by 55.95% reported in 2017Q2 SEC filing. Sun Valley Gold Llc sold 850,000 shares as Iamgold Corp (IAG)’s stock declined 1.76%. The Sun Valley Gold Llc holds 669,088 shares with $3.45M value, down from 1.52 million last quarter. Iamgold Corp now has $2.37B valuation. The stock decreased 0.59% or $0.03 during the last trading session, reaching $5.05. About 2.91 million shares traded. IAMGOLD Corporation (NYSE:IAG) has risen 21.20% since December 11, 2016 and is uptrending. It has outperformed by 4.50% the S&P500.

Among 13 analysts covering Iamgold Corp (NYSE:IAG), 3 have Buy rating, 3 Sell and 7 Hold. Therefore 23% are positive. Iamgold Corp had 42 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Underperform” rating by IBC given on Friday, July 24. On Tuesday, November 7 the stock rating was maintained by BMO Capital Markets with “Buy”. The rating was maintained by BMO Capital Markets on Wednesday, June 28 with “Hold”. The stock of IAMGOLD Corporation (NYSE:IAG) earned “Underweight” rating by Morgan Stanley on Wednesday, November 25. IBC upgraded IAMGOLD Corporation (NYSE:IAG) on Monday, June 27 to “Sector Performer” rating. Canaccord Genuity downgraded it to “Hold” rating and $8.07 target in Friday, September 29 report. The stock of IAMGOLD Corporation (NYSE:IAG) earned “Buy” rating by BMO Capital Markets on Sunday, October 1. The stock of IAMGOLD Corporation (NYSE:IAG) has “Outperformer” rating given on Wednesday, September 6 by IBC. The company was upgraded on Thursday, May 11 by Scotia Capital. The stock has “Underperform” rating by Credit Suisse on Friday, January 13.

The stock decreased 0.14% or $0.09 during the last trading session, reaching $64.9. About 1.96M shares traded. DENTSPLY SIRONA Inc. (XRAY) has risen 2.17% since December 11, 2016 and is uptrending. It has underperformed by 14.53% the S&P500.

Ratings analysis reveals 75% of Dentsply Sirona’s analysts are positive. Out of 4 Wall Street analysts rating Dentsply Sirona, 3 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $63.0 while the high is $70.0. The stock’s average target of $66.50 is 2.47% above today’s ($64.9) share price. XRAY was included in 4 notes of analysts from September 22, 2016. The rating was upgraded by Morgan Stanley on Tuesday, November 1 to “Overweight”. Stifel Nicolaus upgraded the shares of XRAY in report on Tuesday, February 14 to “Buy” rating. On Thursday, September 22 the stock rating was initiated by JP Morgan with “Neutral”. On Monday, December 5 the stock rating was upgraded by Barrington Research to “Outperform”.

Tirschwell & Loewy Inc holds 2.47% of its portfolio in DENTSPLY SIRONA Inc. for 243,211 shares. Cardinal Capital Management owns 70,606 shares or 1.51% of their US portfolio. Moreover, Cibc World Markets Corp has 0.03% invested in the company for 49,396 shares. The Virginia-based Burney Co has invested 0.02% in the stock. Gemmer Asset Management Llc, a California-based fund reported 237 shares.

Analysts await DENTSPLY SIRONA Inc. (NASDAQ:XRAY) to report earnings on February, 16. They expect $0.81 EPS, up 20.90% or $0.14 from last year’s $0.67 per share. XRAY’s profit will be $186.04 million for 20.03 P/E if the $0.81 EPS becomes a reality. After $0.70 actual EPS reported by DENTSPLY SIRONA Inc. for the previous quarter, Wall Street now forecasts 15.71% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *